60 Degrees Pharmaceuticals (SCTP) Proxy Filing summary

Executive summary

• Special Meeting scheduled for November 6, 2024, to be held virtually via telephone for all stockholders of record as of September 20, 2024.

• Proxy materials distributed primarily via internet to expedite delivery, reduce costs, and conserve resources.

• Four key proposals will be presented for stockholder approval, with the Board recommending a vote in favor of each.

Voting matters and shareholder proposals

• Proposal 1: Approval of the exercise of warrants issued on September 5, 2024, to purchase up to 6,014,493 shares of common stock, subject to Nasdaq rules.

• Proposal 2: Amendment to the 2022 Equity Incentive Plan to increase shares available for issuance by 500,000.

• Proposal 3: Amendment to the certificate of incorporation to effect a reverse stock split at a ratio between 1:3 and 1:5, at the Board's discretion.

• Proposal 4: Approval to adjourn the meeting if additional proxies are needed to pass the above proposals.

• Board unanimously recommends voting “FOR” all proposals.

Board of directors and corporate governance

• Board retains discretion to implement or abandon the reverse stock split at any time within one year of approval.

• No director or officer has a substantial interest in any of the proposals beyond that of all other stockholders.

• Procedures for stockholder proposals and director nominations for the 2025 annual meeting are outlined.